Literature DB >> 433898

Hepatitis B antigen and antibody in heroin users.

R R Blanck, N Ream, M Conrad.   

Abstract

Hepatitis B surface antigen (HBsAg) and antibody (anti-HBsAg) were determined on 442 asymptomatic heroin users and 246 controls. Of the drug-taking group, 124 used heroin intravenously and 318 nonintravenously (smoking, sniffing). Twenty-three (5.2%) heroin users were HBsAg positive and 118 (26.7%) anti-HBsAg positive, compared to three (1.2%) HBsAg positive and 28 (11.4%) anti-HBsAg positive controls, both statistically significant. HBsAg was positive in eight (6.5%) intravenous heroin users and statistically identical to 15 (4.7%) HBsAg positive nonintravenous users. Positive anti-HBsAg in 55 (44.4%) intravenous heroin users compared to 63 (19.8%) nonintravenous users, however, is statistically significicant.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433898

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  7 in total

1.  Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: the UFO Study.

Authors:  Paula J Lum; Kristen C Ochoa; Judith A Hahn; Kimberly Page Shafer; Jennifer L Evans; Andrew R Moss
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

2.  Cost without benefit? The introduction of hepatitis B vaccine in Canada.

Authors:  R A Coates; J G Rankin
Journal:  Can Med Assoc J       Date:  1983-05-15       Impact factor: 8.262

3.  Epidemic hepatitis B with delta-antigenaemia among Dublin drug-abusers.

Authors:  A G Shattock; M G Kelly; J Fielding; Y Arthurs
Journal:  Ir J Med Sci       Date:  1982-11       Impact factor: 1.568

4.  Low prevalence of hepatitis B markers among Mexican female sex workers.

Authors:  L Juárez-Figueroa; F Uribe-Salas; C Conde-Glez; M Hernández-Avila; M Olamendi-Portugal; P Uribe-Zúñiga; E Calderón
Journal:  Sex Transm Infect       Date:  1998-12       Impact factor: 3.519

5.  Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users.

Authors:  J D Rich; B J Anderson; B Schwartzapfel; M D Stein
Journal:  Epidemiol Infect       Date:  2005-09-30       Impact factor: 2.451

6.  Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers.

Authors:  I V Weller; D Cohn; A Sierralta; M Mitcheson; M G Ross; L Montano; P Scheuer; H C Thomas
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

7.  Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff.

Authors:  M Chiaramonte; R Trivello; G Renzulli; L Zampieri; A Fanecco; A Floreani; R Naccarato
Journal:  J Hyg (Lond)       Date:  1982-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.